Identification of Endothelin-1 and NR4A2 as CD133-regulated genes in colon cancer cells

Journal of Pathology

Volumn 225, Issue 2, 2011, Pages 305-314

  Puglisi, Maria Ausiliatrice ^a   Barba, Marta ^a   Corbi, Maddalena ^a   Errico, Maria Federica ^a   Giorda, Ezio ^b   Saulnier, Nathalie ^a   Boninsegna, Alma ^a   Piscaglia, Anna Chiara ^a   Carsetti, Rita ^b   Cittadini, Achille ^a   Gasbarrini, Antonio ^a   Sgambato, Alessandro ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

CD133; Endothelin 1; NR4A2; side population

Indexed keywords

BUTYRIC ACID; CD133 ANTIGEN; ENDOTHELIN 1; NUCLEAR RECEPTOR RELATED FACTOR 1; SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; CANCER STEM CELL; CELL DIFFERENTIATION; COLON CANCER; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; MICROARRAY ANALYSIS; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIDE POPULATION CELL;

ANTIGENS, CD; BLOTTING, WESTERN; CACO-2 CELLS; CELL SEPARATION; COLONIC NEOPLASMS; ENDOTHELIN-1; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOPROTEINS; HUMANS; IMMUNOPHENOTYPING; NEOPLASTIC STEM CELLS; NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 2; PEPTIDES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 80052462125     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2954     Document Type: Article

References (31)

1. Piscaglia AC, Shupe TD, Petersen BE, et al., Stem cells, cancer, liver, and liver cancer stem cells: finding a way out of the labyrinth. Curr Cancer Drug Targets 2007; 7: 582-590. (Pubitemid 47358144)
2. Reya T, Morrison SJ, Clarke MF, et al., Stem cells, cancer, and cancer stem cells. Nature 2001; 414: 105-111. (Pubitemid 33041634)
3. Clarke MF, Dick JE, Dirks PB, et al., Cancer stem cells: perspectives on current status and future directions. AACR Workshop on Cancer Stem Cells. Cancer Res 2006; 66: 9339-9344. (Pubitemid 44623625)
4. Ricci-Vitiani L, Lombardi DG, Pilozzi E, et al., Identification and expansion of human colon cancer-initiating cells. Nature 2007; 445: 111-115. (Pubitemid 46067311)
5. O'Brien CA, Pollett A, Gallinger S, et al., A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007; 445: 106-110. (Pubitemid 46067310)
6. Mizrak D, Brittan M, Alison MR,. CD133: molecule of the moment. J Pathol 2008; 214: 3-9.
7. - metastatic colon cancer cells initiate tumors. J Clin Invest 2008; 118: 2111-2120. (Pubitemid 351872330)
8. Chu P, Clanton DJ, Snipas TS, et al., Characterization of a subpopulation of colon cancer cells with stem cell-like properties. Int J Cancer 2009; 124: 1312-1321.
9. Zhou S, Schuetz JD, Bunting KD, et al., The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med 2001; 7: 1028-1034. (Pubitemid 32937383)
10. Asakura A, Rudnicki MA,. Side population cells from diverse adult tissues are capable of in vitro haematopoietic differentiation. Exp Hematol 2002; 30: 1339-1345. (Pubitemid 35287588)
11. Hirschmann-Jax C, Foster AE, Wulf GG, et al., A distinct 'side population' of cells with high drug efflux capacity in human tumourcells. Proc Natl Acad Sci USA 2004; 101: 14228-14233. (Pubitemid 39305058)
12. Burkert J, Otto WR, Wright NA,. Side populations of gastrointestinal cancers are not enriched in stem cells. J Pathol 2008; 214: 564-573. (Pubitemid 351482271)
13. Sgambato A, Migaldi M, Montanari M, et al., Dystroglycan expression is frequently reduced in human breast and colon cancers and is associated with tumour progression. Am J Pathol 2003; 162: 849-860. (Pubitemid 36237493)
14. Sgambato A, Di Salvatore MA, De Paola B, et al., Analysis of dystroglycan regulation and functions in mouse mammary epithelial cells and implications for mammary tumorigenesis. J Cell Physiol 2006; 207: 520-529.
15. Sgambato A, Puglisi M.A., Errico F, et al., A post-translational modulation of CD133 expression during sodium butyrateinduced differentiation of HT29 human colon cancer cells: implications for its detection. J Cell Physiol 2010; 224: 234-241.
16. + cell population within human primary and metastatic colon cancer. Eur Rev Med Pharmacol Sci 2009; 13 (suppl 1): 55-62.
17. Sgambato A, De Paola B, Migaldi M, et al., Dystroglycan expression is reduced during prostate tumorigenesis and is regulated by androgens in prostate cancer cells. J Cell Physiol 2007; 213: 528-539. (Pubitemid 47509736)
18. Sgambato A, Camerini A, Montanari M, et al., Increased expression of dystroglycan inhibits the growth and tumorigenicity of human mammary epithelial cells. Cancer Biol Ther 2004; 3: 849-860.
19. Sgambato A, Errico F, Caredda E, et al., Divergent expression of CD133 in different studies: the need for a consensus panel? Int J Cancer 2010; DOI: 10.1002/ijc.25551.
20. Nelson J, Bagnato A, Battistini B, et al., The endothelin axis: emerging role in cancer. Nat Rev Cancer 2003; 3: 110-116. (Pubitemid 37328878)
21. Basu GD, Azorsa DO, Kiefer JA, et al., Functional evidence implicating S100P in prostate cancer progression. Int J Cancer 2008; 123: 330-339. (Pubitemid 351842017)
22. Suzuki S, Suzuki N, Mirtsos C, et al., Nur77 as a survival factor in tumour necrosis factor signaling. Proc Natl Acad Sci USA 2003; 100: 8276-8280. (Pubitemid 36842535)
23. Ke N, Claassen G, Yu DH, et al., Nuclear hormone receptor NR4A2 is involved in cell transformation and apoptosis. Cancer Res 2004; 64: 8208-8212. (Pubitemid 39491757)
24. Yamazaki D, Kurisu S, Takenawa T,. Regulation of cancer cell motility through actin reorganization. Cancer Sci 2005; 96: 379-386. (Pubitemid 41179738)
25. Halder SK, Rachakonda G, Deane NG, et al., Smad7 induces hepatic metastasis in colorectal cancer. Br J Cancer 2008; 99: 957-965.
26. Dalerba P, Dylla SJ, Park IK, et al., Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci USA 2007; 104: 10158-10163. (Pubitemid 47175279)
27. Mangelsdorf DJ, Thummel C, Beato M, et al., The nuclear receptor superfamily: the second decade. Cell 1995; 83: 835-839.
28. Winoto A, Littman DR,. Nuclear hormone receptors in T lymphocytes. Cell 2002; 109: S57-66. (Pubitemid 34457852)
29. Cheng LE, Chan FK, Cado D, et al., Functional redundancy of the Nur77 and Nor-1 orphan steroid receptors in T-cell apoptosis. EMBO J 1997; 16: 1865-1875. (Pubitemid 27170948)
30. Ke N, Claassen G, Yu DH, et al., Nuclear hormone receptor NR4A2 is involved in cell transformation and apoptosis. Cancer Res 2004; 64: 8208-8212. (Pubitemid 39491757)
31. Holla VR, Mann JR, Shi Q, et al., Prostaglandin E2 regulates the nuclear receptor NR4A2 in colorectal cancer. Biol Chem 2006; 281: 2676-2682. (Pubitemid 43845730)